期刊
NATURE MEDICINE
卷 18, 期 7, 页码 1028-1040出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nm.2807
关键词
-
资金
- US National Institutes of Health
- National Institute of Allergy and Infectious Diseases
- Pfizer
- MedImmune
- Amgen
- Regeneron
- Centocor
- Genentech
Fibrosis is a pathological feature of most chronic inflammatory diseases. Fibrosis, or scarring, is defined by the accumulation of excess extracellular matrix components. If highly progressive, the fibrotic process eventually leads to organ malfunction and death. Fibrosis affects nearly every tissue in the body. Here we discuss how key components of the innate and adaptive immune response contribute to the pathogenesis of fibrosis. We also describe how cell-intrinsic changes in important structural cells can perpetuate the fibrotic response by regulating the differentiation, recruitment, proliferation and activation of extracellular matrix-producing myofibroblasts. Finally, we highlight some of the key mechanisms and pathways of fibrosis that are being targeted as potential therapies for a variety of important human diseases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据